Singapore markets open in 5 hours 50 minutes
Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,067.92 +57.32 (+1.14%) Dow
38,480.47 +240.49 (+0.63%) Nasdaq
15,702.05 +250.75 (+1.62%) Bitcoin USD
66,715.30 +346.79 (+0.52%) CMC Crypto 200
1,434.67 +19.91 (+1.41%)
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:10PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.39B |
| Enterprise value | 980.49M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.49 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -6.53 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.87 |
| 52-week change 3 | 69.52% |
| S&P500 52-week change 3 | 23.06% |
| 52-week high 3 | 24.17 |
| 52-week low 3 | 7.41 |
| 50-day moving average 3 | 20.70 |
| 200-day moving average 3 | 13.64 |
Share statistics
| Avg vol (3-month) 3 | 1.44M |
| Avg vol (10-day) 3 | 999.14k |
| Shares outstanding 5 | 76.18M |
| Implied shares outstanding 6 | 76.18M |
| Float 8 | 49.82M |
| % held by insiders 1 | 1.75% |
| % held by institutions 1 | 105.63% |
| Shares short (28 Mar 2024) 4 | 10.41M |
| Short ratio (28 Mar 2024) 4 | 9.57 |
| Short % of float (28 Mar 2024) 4 | 13.86% |
| Short % of shares outstanding (28 Mar 2024) 4 | 13.67% |
| Shares short (prior month 29 Feb 2024) 4 | 11.02M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -22.90% |
| Return on equity (ttm) | -37.34% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -164.96M |
| Net income avi to common (ttm) | -152.63M |
| Diluted EPS (ttm) | -2.08 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 423.96M |
| Total cash per share (mrq) | 5.57 |
| Total debt (mrq) | 17.2M |
| Total debt/equity (mrq) | 4.33% |
| Current ratio (mrq) | 12.26 |
| Book value per share (mrq) | 5.34 |
Cash flow statement
| Operating cash flow (ttm) | -124.82M |
| Levered free cash flow (ttm) | -63.9M |
© 2024 Yahoo. All rights reserved.